Laurel T. Bate-Eya
Advances in Neuroblastoma Research Congress 2016
Days
Sunday, 19th June
Monday, 20th June
Tuesday, 21st June
Wednesday, 22nd June
Thursday, 23rd June
Friday, 24th June
Search
Speakers
Laurel T. Bate-Eya
Abstracts this author is presenting:
High efficacy of the BCL-2 inhibitor venetoclax (ABT-199) in neuroblastoma and rational for combination therapy.
—
Poster Session 2 with wine & cheese
EZH2 is highly expressed in neuroblastoma and plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity.
—
Poster Session 1 with wine & cheese